Loading data...
Loading data...
Compare up to 4 stocks side by side, across all 7 of StockIQ's scoring categories.
| Category | AAPG Ascentage Pharma Group International - American Depository | AARD Aardvark Therapeutics, Inc. |
|---|---|---|
| Price | $16.41 +1.9% | $5.55 +8.2% |
| StockIQ Score | 35F Weak Risk: High | 47D+ Moderate Risk: High |
| Technical | 13F | 34F |
| Fundamental | 35F | 46D+ |
| Growth | 50C- | 46D+ |
| Fair Value | 38F | 50C- |
| News | 50C- | 80A- |
| Quality | 50C- | — |
| Risk | 40D | 40D |
Scores are based on real financial data only and do not constitute investment advice. How the score is calculated
Aardvark Therapeutics (AARD) outperforms Ascentage Pharma (AAPG) in investor sentiment, fundamentals, and valuation, scoring 47, 46, and 55 respectively, compared to AAPG’s 37, 35, and 38. However, AAPG shows stronger growth potential with a score of 50 versus AARD’s 46. AARD’s overall rating is moderate, while AAPG is rated weak.